Quantifying the impact of the COVID-19 pandemic on clinical trial screening rates over time in 37 countries. As of this writing, more than 669 million confirmed cases of SARS-CoV-2 infection have been reported globally. More than 1.02 million people in the USA alone have died due to the outbreak, including 1.74 million in the U.S. We focus on the impact on clinical trials from the onset of the outbreak and demonstrate how the subsequent changes in the distribution and severity of the pandemic relate to trial screening over time.